AKT1 and rheumatoid arthritis: Studies have demonstrated that celastrol inhibits the PI3K/AKT/mTOR signaling pathway, increases the autophagosome level of FLS, decreases the phosphorylation of mTOR and AKT, and induces autophagy, thus ameliorating RA (234).